IBRX - ImmunityBio, Inc.
3
0.010 0.333%
Share volume: 4,124,543
Last Updated: 03-07-2025
Research and Development in Biotechnology (except Nanobiotechnology):
-0.45%
PREVIOUS CLOSE
CHG
CHG%
$2.99
0.01
0.00%
Summary score
32%
Profitability
25%
Dept financing
25%
Liquidity
75%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
27.48%
Return on assets
-25.61%
Return on sales
-140986.96%
Return on invested capital
-56.03%
Total debt ratio
215.93%
Debt ratio change over timeo
-0.77%
Current Ratio
1.94%
Quick Ratio
1.83%
Cash Position Ratio
1.54%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
29.57%
Return on assets
-20.06%
Return on sales
-109515.05%
Return on invested capital
-121.08%
Total debt ratio
264.67%
Debt ratio change over timeo
-3.36%
Current Ratio
3.78%
Quick Ratio
3.8%
Cash Position Ratio
2.83%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-12.98%
Return on sales
-1314.33%
Return on invested capital
0%
Total debt ratio
304.39%
Debt ratio change over time
-4.43%
Current Ratio
2.68%
Quick Ratio
2.64%
Cash Position Ratio
1.84%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-84.6%
Return on assets
-108.46%
Return on sales
-42415.57%
Return on invested capital
-84.99%
Total debt ratio
-76.98%
Debt ratio change over time
-0.77%
Current Ratio
-1.45%
Quick Ratio
-1.32%
Cash Position Ratio
-1.37%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IBRX | ABBV | AMGN | GILD |
|---|---|---|---|---|
| Return on equity | 27.48% | 16.27% | 18.34% | 4.52% |
| Return on assets | -25.61% | 2.36% | 3.17% | 3.15% |
| Return on sales | -140986.96% | 28.88% | 30.73% | 29.2% |
| Return on invested capital | -56.03% | 2.59% | 5.33% | 2.28% |
| Profitability | 25% | 69% | 92% | 63% |
| Total debt ratio | 215.93% | 91.15% | 91.7% | 67.74% |
| Debt ratio change over time | -0.77% | 100.91% | 17.73% | 109.18% |
| Dept financing | 25% | 34% | 15% | 33% |
| Current Ratio | 3.78% | 0.82% | 1.41% | 1.2% |
| Quick Ratio | 3.8% | 0.71% | 0.99% | 1.04% |
| Cash Position Ratio | 2.83% | 0.31% | 0.49% | 0.43% |
| Liquididy | 75% | 27% | 57% | 41% |
| Short-term ratios | IBRX | ABBV | AMGN | GILD |
|---|---|---|---|---|
| Return on equity | 29.57% | 0% | 0% | -8.76% |
| Return on assets | -20.06% | 1.6% | 2.14% | 1.23% |
| Return on sales | -109515.05% | 24.8% | 18.91% | 9.38% |
| Return on invested capital | -121.08% | 0% | 0% | -5.08% |
| Profitability | 25% | 44% | 69% | 24% |
| Total debt ratio | 264.67% | 94.49% | 93.35% | 66.59% |
| Debt ratio change over time | -3.36% | 0% | 0% | 5.11% |
| Dept financing | 25% | 9% | 9% | 31% |
| Current Ratio | 3.78% | 0.82% | 1.41% | 1.2% |
| Quick Ratio | 3.8% | 0.71% | 0.99% | 1.04% |
| Cash Position Ratio | 2.83% | 0.31% | 0.49% | 0.43% |
| Liquididy | 75% | 13% | 20% | 19% |